Synergistic effect of clinically used antibiotics and peptide antibiotics against Gram-positive and Gram-negative bacteria.

Yuling Zhou, Yan Peng
Author Information
  1. Yuling Zhou: Department of Respiratory Medicine, Xinxiang Central Hospital of Henan Province, Xinxiang, Henan 453000, P.R. China.

Abstract

Ribosomally synthesized (natural) peptides demonstrate antimicrobial potency and may represent a novel therapeutic approach for the treatment of infections. The aim of the present study was to investigate the interaction between polycationic peptides and clinically used antimicrobial agents in the treatment of clinical isolates of Gram-positive and Gram-negative aerobic bacteria using the microbroth dilution method. The combination studies demonstrated synergies between ranalexin and polymyxin E, doxycycline and clarithromycin. Similarly, magainin II was demonstrated to be synergistic with ceftriaxone, amoxicillin clavulanate, ceftazidime, meropenem, piperacillin and β-lactam antibiotics. Buforin II, cecropin P1 and indolicidin were not observed to be synergistic with the clinically used antibiotics, but demonstrated additive effects with them. Notably, no antagonistic effects were identified in all the combinations examined.

Keywords

References

  1. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4761-5 [PMID: 1693777]
  2. Mol Microbiol. 1994 Jun;12(6):951-8 [PMID: 7934902]
  3. Proc Natl Acad Sci U S A. 1989 Dec;86(23):9159-62 [PMID: 2512577]
  4. Antimicrob Agents Chemother. 1993 Sep;37(9):1749-55 [PMID: 8239580]
  5. Clin Microbiol Rev. 2006 Jul;19(3):491-511 [PMID: 16847082]
  6. Biochemistry. 1991 May 14;30(19):4671-8 [PMID: 1903066]
  7. Antimicrob Agents Chemother. 1997 Feb;41(2):481-3 [PMID: 9021214]
  8. Insect Biochem Mol Biol. 1999 Jan;29(1):19-24 [PMID: 10070741]
  9. Antimicrob Agents Chemother. 1997 Apr;41(4):771-5 [PMID: 9087487]
  10. J Antimicrob Chemother. 1997 Aug;40(2):153-5 [PMID: 9301978]
  11. Arch Microbiol. 1995 Dec;164(6):383-9 [PMID: 8588739]
  12. Antimicrob Agents Chemother. 1996 Aug;40(8):1801-5 [PMID: 8843284]
  13. Annu Rev Microbiol. 1987;41:103-26 [PMID: 3318666]
  14. J Antibiot (Tokyo). 1991 May;44(5):517-23 [PMID: 1648055]
  15. J Biol Chem. 1994 Apr 8;269(14):10849-55 [PMID: 8144672]
  16. J Med Microbiol. 1997 Jan;46(1):1-3 [PMID: 9003734]
  17. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5449-53 [PMID: 3299384]
  18. Peptides. 1999 Nov;20(11):1265-73 [PMID: 10612440]
  19. Int J Antimicrob Agents. 2005 May;25(5):448-9 [PMID: 15848303]
  20. J Antimicrob Chemother. 1993 May;31(5):681-8 [PMID: 8392997]
  21. Int J Antimicrob Agents. 2004 Dec;24(6):536-47 [PMID: 15555874]
  22. J Biol Chem. 1996 Aug 9;271(32):19298-303 [PMID: 8702613]
  23. FEBS Lett. 1996 Nov 25;398(1):87-90 [PMID: 8946958]
  24. Annu Rev Biochem. 1990;59:129-70 [PMID: 1695830]
  25. Biochemistry. 1985 Mar 26;24(7):1683-8 [PMID: 3924096]
  26. Arch Intern Med. 1994 Jan 10;154(1):26-34 [PMID: 8267486]
  27. J Antimicrob Chemother. 1996 Jun;37(6):1077-89 [PMID: 8836811]

Word Cloud

Created with Highcharts 10.0.0antibioticsbacteriaclinicallyusedGram-positiveGram-negativeaerobicdemonstratedpeptidesantimicrobialtreatmentIIsynergisticeffectspeptideRibosomallysynthesizednaturaldemonstratepotencymayrepresentnoveltherapeuticapproachinfectionsaimpresentstudyinvestigateinteractionpolycationicagentsclinicalisolatesusingmicrobrothdilutionmethodcombinationstudiessynergiesranalexinpolymyxinEdoxycyclineclarithromycinSimilarlymagaininceftriaxoneamoxicillinclavulanateceftazidimemeropenempiperacillinβ-lactamBuforincecropinP1indolicidinobservedadditiveNotablyantagonisticidentifiedcombinationsexaminedSynergisticeffectsynergy

Similar Articles

Cited By